IP Library Granted Patent US 11,911,555
Granted Patent B2
US 11,911,555 · App. 17/154,193 · Granted Feb 27, 2024

Cellulite treatment system and methods

Inventors: Joshua Makower (Los Altos Hills, CA); Jonathan Podmore (San Carlos, CA); Earl Bright, II (Sunnyvale, CA); John Hanley (Manhattan Beach, CA); Pablo Acosta (Newark, CA); Theodore Ketai (Chico, CA); William Sauway Law (Palo Alto, CA); Bryan Hartley (Redwood City, CA)
Assignee: Revelle Aesthetics, Inc.
A61M1/85A61B5/0059A61B5/444A61B17/32075A61M29/02A61B2217/005A61H2207/00A61M2029/025A61M2210/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,911,555
App. No.
17/154,193
Granted
Feb 27, 2024
Kind
B2
Abstract

Systems and methods for treating cellulite including an apparatus that applies or a method involving disrupting, stretching, re-orienting or tearing septa to eliminate or reduce the appearance of cellulite. In one approach, an expandable member is placed between tissue layers to stretch or tear septa connecting tissue layers between which fat deposits are contained.

Claims (15)

1. A cellulite treatment method comprising:

identifying a treatment site where cellulite exists;

employing an engagement device to provide a stable foundation without pulling tissue into a cavity or recess;

selecting a depth to be accessed between tissue layers;

creating an insertion site with a needle;

advancing the needle in a direction parallel to skin overlying the treatment site;

after creating an insertion site releasing tissue;

advancing an expandable dilator within the insertion site to an interventional site using transillumination; and

expanding the expandable dilator to rupture without cutting at least a septum at the interventional site.

2. The method of claim 1 , further comprising creating a treatment regimen involving employing the insertion site to treat multiple areas.

3. The method of claim 1 , further comprising advancing a hypotube over the needle.

4. The method of claim 1 , further comprising advancing a guidewire within a hypotube.

5. The method of claim 1 , further comprising advancing the expandable dilator over a guidewire.

6. The method of claim 1 , further comprising manipulating the expandable dilator to stretch or re-orient septa connecting tissue layers.

7. The method of claim 1 , further comprising scanning skin of a subject to identify treatment areas and create a treatment regimen, a scanning date being stored so that the efficacy of the cellulite treatment can be assessed.

Assignments (2)
SECURITY INTEREST Recorded May 31, 2023
From: REVELLE AESTHETICS, INC.
To: TRINITY CAPITAL INC.
Reel/Frame 063803/0159 →
CHANGE OF NAME Recorded Jul 19, 2021
From: NC8, INC.
To: REVELLE AESTHETICS, INC
Reel/Frame 056907/0642 →
Continuity (5)
Continuation PCTUS2019042865 · Jul 22, 2019
Provisional Application 62798515 · Jan 30, 2019
Provisional Application 62736016 · Sep 25, 2018
Provisional Application 62702314 · Jul 23, 2018
Related Publication 20210138127A1 · May 13, 2021